Gabriel García-Rodríguez
Biographic Data
| ID | 142309 |
|---|---|
| NAME | Gabriel García-Rodríguez |
| GIVEN NAMES | Gabriel |
| FAMILY NAME | García-Rodríguez |
| SIGNATURE | GARCÍA-RODRÍGUEZ G |
| AFFILIATIONS | Dirección General de Epidemiología, Ciudad de México, México. |
| ORCID | 0000-0002-1227-0687 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Risk Factors Associated to Mortality in the Indigenous Population with Covid-19 in Mexico
OBJECTIVE: During the COVID-19 pandemic, the Indigenous population in Mexico was subject to several factors that caused them to have a higher mortality risk than the non-Indigenous population. These risk factors included language barriers, poverty, comorbidities, inadequate access to health services, lack of social security, limited education, and substandard housing, inter alia. This study aims to determine the factors associated with COVID-19 m…
Desafíos y estrategias para responder al brote de sarampión durante la pandemia por Covid-19 en México, tras 25 años poseliminación
A very important factor in controlling the outbreak was to strengthen the training and coordination of rapid response teams belonging to local health districts, states, the national network of government-operated public health laboratories, and the national laboratory supporting epidemiological surveillance (LAVE). On 31 August 2020, after 90 days of active surveillance and reports of negative test results from the network of health units and lab…
Protection of hybrid immunity against Sars-CoV-2 reinfection and severe Covid-19 during periods of Omicron variant predominance in Mexico
Background: With the widespread transmission of the Omicron SARS-CoV-2 variant, reinfections have become increasingly common. Here, we explored the role of immunity, primary infection severity, and variant predominance in the risk of reinfection and severe COVID-19 during Omicron predominance in Mexico. Methods: We analyzed reinfections in Mexico in individuals with a primary infection separated by at least 90 days from reinfection using a nation…
No prominent works on this page.
Protection of hybrid immunity against Sars-CoV-2 reinfection and severe Covid-19 during periods of Omicron variant predominance in Mexico
Background: With the widespread transmission of the Omicron SARS-CoV-2 variant, reinfections have become increasingly common. Here, we explored the role of immunity, primary infection severity, and variant predominance in the risk of reinfection and severe COVID-19 during Omicron predominance in Mexico. Methods: We analyzed reinfections in Mexico in individuals with a primary infection separated by at least 90 days from reinfection using a nation…
Desafíos y estrategias para responder al brote de sarampión durante la pandemia por Covid-19 en México, tras 25 años poseliminación
A very important factor in controlling the outbreak was to strengthen the training and coordination of rapid response teams belonging to local health districts, states, the national network of government-operated public health laboratories, and the national laboratory supporting epidemiological surveillance (LAVE). On 31 August 2020, after 90 days of active surveillance and reports of negative test results from the network of health units and lab…
Risk Factors Associated to Mortality in the Indigenous Population with Covid-19 in Mexico
OBJECTIVE: During the COVID-19 pandemic, the Indigenous population in Mexico was subject to several factors that caused them to have a higher mortality risk than the non-Indigenous population. These risk factors included language barriers, poverty, comorbidities, inadequate access to health services, lack of social security, limited education, and substandard housing, inter alia. This study aims to determine the factors associated with COVID-19 m…
Medicine (3 works) · Biology (2 works) · Epidemiology (2 works) · Internal Medicine (2 works) · Virology (2 works) · 2019-20 coronavirus outbreak (1 work) · Antigen (1 work) · Booster dose (1 work) · Case fatality rate (1 work) · Coronavirus disease 2019 (COVID-19 (1 work)